Extracellular matrix proteins in hemostasis and thrombosis

Cold Spring Harbor Perspectives in Biology

Volumn 4, Issue 2, 2012, Pages

  Bergmeier, Wolfgang ^a   Hynes, Richard O ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SCLEROPROTEIN;

ANIMAL; BLOOD; EXTRACELLULAR MATRIX; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESIVENESS; THROMBOSIS;

ANIMALS; BLOOD PLATELETS; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; HUMANS; PLATELET ACTIVATION; PLATELET ADHESIVENESS; THROMBOSIS;

EID: 84863933914     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a005132     Document Type: Article

References (120)

1. Andrews RK, Gardiner EE, Shen Y, Whisstock JC, Berndt MC. 2003. Glycoprotein Ib-IX-V. Int J Biochem Cell Biol 35: 1170-1174.
2. Andrews RK, Du X, Berndt MC. 2007. The 14-3-3 ζ-GPIb-IX-V complex as an antiplatelet target. Drug News Perspect 20: 285-292.
3. Arai M, Yamamoto N, Moroi M, Akamatsu N, Fukutake K, Tanoue K. 1995. Platelets with 10% of the normal amount of glycoprotein VI have an impaired response to collagen that results in a mild bleeding tendency. Br J Haematol 89: 124-130.
4. Arya M, Lopez JA, Romo GM, Dong JF, McIntire LV, Moake JL, Anvari B. 2002. Measurement of the binding forces between von Willebrand factor and variants of platelet glycoprotein Ibα using optical tweezers. Lasers Surg Med 30: 306-312.
5. Assoian RK, Sporn MB. 1986. Type β transforming growth factor in human platelets: Release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol 102: 1217-1223.
6. Astrof S, Hynes RO. 2009. Fibronectins in vascular morphogenesis. Angiogenesis 12: 165-175.
7. Astrof S, Crowley D, Hynes RO. 2007.Multiple cardiovascular defects caused by the absence of alternatively spliced segments of fibronectin. Dev Biol 311: 11-24.
8. Banno F, Kokame K, Okuda T, Honda S, Miyata S, Kato H, Tomiyama Y, Miyata T. 2006. Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura. Blood 107: 3161-3166.
9. Bennett JS, Berger BW, Billings PC. 2009. The structure and function of platelet integrins. J Thromb Haemost 7 (Suppl 1): 200-205.
10. Bergmeier W, Piffath CL, Goerge T, Cifuni SM, Ruggeri ZM, Ware J, Wagner DD. 2006. The role of platelet adhesion receptor GPIbα far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis. Proc Natl Acad Sci 103: 16900-16905.
11. Bergmeier W, Chauhan AK, Wagner DD. 2008. Glycoprotein Ibα and von Willebrand factor in primary platelet adhesion and thrombus formation: Lessons from mutant mice. Thromb Haemost 99: 264-270.
12. Bernard J, Soulier JP. 1948. Sur une nouvelle variete de dystrophie thrombocytaire-hemorragipare congenitale. Semin Hop Paris 24: 3217-3223.
13. Brass LF, Jiang H, Wu J, Stalker TJ, Zhu L. 2006. Contactdependent signaling events that promote thrombus formation. Blood Cells Mol Dis 36: 157-161.
14. Caen JP, Nurden AT, Jeanneau C, Michel H, Tobelem G, Levy-Toledano S, Sultan Y, Valensi F, Bernard J. 1976. Bernard-Soulier syndrome: A new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the factor VIII vonWillebrand protein. J Lab Clin Med 87: 586-596.
15. Campbell ID, Humphries MJ. 2011. Integrin structure, activation, and interactions. Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a004994.
16. Chauhan AK, Kisucka J, Lamb CB, Bergmeier W, Wagner DD. 2007. vonWillebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins. Blood 109: 2424-2429.
17. Chauhan AK, Kisucka J, Cozzi MR, Walsh MT, Moretti FA, Battiston M, Mazzucato M, De Marco L, Baralle FE, Wagner DD, et al. 2008. Prothrombotic effects of fibronectin isoforms containing the EDA domain. Arterioscler Thromb Vasc Biol 28: 296-301.
18. Chen Z, Lou J, Zhu C, Schulten K. 2008. Flow-induced structural transition in the β-switch region of glycoprotein Ib. Biophys J 95: 1303-1313.
19. Cho J, Mosher DF. 2006. Enhancement of thrombogenesis by plasma fibronectin cross-linked to fibrin and assembled in platelet thrombi. Blood 107: 3555-3563.
20. Clemetson KJ, Clemetson JM. 2001. Platelet collagen receptors. Thromb Haemost 86: 189-197.
21. Clemetson KJ, Clemetson JM. 2008. Platelet GPIb complex as a target for anti-thrombotic drug development. Thromb Haemost 99: 473-479.
22. Cosemans JM, Kuijpers MJ, Lecut C, Loubele ST, Heeneman S, Jandrot-Perrus M, Heemskerk JW. 2005. Contribution of platelet glycoprotein VI to the thrombogenic effect of collagens in fibrous atherosclerotic lesions. Atherosclerosis 181: 19-27.
23. Crittenden JR, Bergmeier W, Zhang Y, Piffath CL, Liang Y, Wagner DD, Housman DE, Graybiel AM. 2004. CalDAGGEFI integrates signaling for platelet aggregation and thrombus formation. Nat Med 10: 982-986.
24. Dale GL. 2005. Coated-platelets: An emerging component of the procoagulant response. J Thromb Haemost 3: 2185-2192.
25. Deckmyn H, Cauwenberghs N, Wu D, Depraetere H, Vanhoorelbeke K. 2005. Development of antibodies that interfere with the collagen-VWF-GPIb axis as new antithrombotics. Verh K Acad Geneeskd Belg 67: 55-65.
26. DeMeyer SF, Vanhoorelbeke K, Broos K, Salles II, Deckmyn H. 2008. Antiplatelet drugs. Br J Haematol 142: 515-528.
27. Denis CV, Wagner DD. 2007. Platelet adhesion receptors and their ligands in mouse models of thrombosis. Arterioscler Thromb Vasc Biol 27: 728-739.
28. Denis C, Methia N, Frenette PS, Rayburn H, Ullman-Cullere M, Hynes RO, Wagner DD. 1998. A mouse model of severe von Willebrand disease: Defects in hemostasis and thrombosis. Proc Natl Acad Sci 95: 9524-9529.
29. Doggett TA, Girdhar G, Lawshe A, Miller JL, Laurenzi IJ, Diamond SL, Diacovo TG. 2003. Alterations in the intrinsic properties of the GPIbα -VWF tether bond define the kinetics of the platelet-type von Willebrand disease mutation, Gly233Val. Blood 102: 152-160.
30. Du X. 2007. Signaling and regulation of the platelet glycoprotein Ib-IX-V complex. Curr Opin Hematol 14: 262-269.
31. Dubois C, Panicot-Dubois L, Merrill-Skoloff G, Furie B, Furie BC. 2006. Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo. Blood 107: 3902-3906.
32. Dumas JJ, Kumar R, McDonagh T, Sullivan F, Stahl ML, Somers WS, Mosyak L. 2004. Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Iba complex reveals conformation differenceswith a complex bearing von Willebrand disease mutations. J Biol Chem 279: 23327-23334.
33. Dumont B, Lasne D, Rothschild C, Bouabdelli M, Ollivier V, Oudin C, Ajzenberg N, Grandchamp B, Jandrot-Perrus M. 2009. Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations. Blood 114: 1900-1903.
34. Emsley J, Knight CG, Farndale RW, Barnes MJ, Liddington RC. 2000. Structural basis of collagen recognition by integrin α2β 1. Cell 101: 47-56.
35. Furlan M, Lammle B. 2001. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: The role of von Willebrand factorcleaving protease. Best Pract Res Clin Haematol 14: 437-454.
36. Gruner S, Prostredna M, Aktas B, Moers A, Schulte V, Krieg T, Offermanns S, Eckes B, Nieswandt B. 2004. Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced α2β 1 levels or concomitant aspirin therapy. Circulation 110: 2946-2951.
37. Hallmann R, Horn N, Selg M, Wendler O, Pausch F, Sorokin LM. 2005. Expression and function of laminins in the embryonic and mature vasculature. Physiol Rev 85: 979-1000.
38. Harper MT, Poole AW. 2010. Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation. J Thromb Haemost 8: 454-462.
39. Hechler B, Gachet C. 2011. Comparison of two murine models of thrombosis induced by atherosclerotic plaque injury. Thromb Haemost 105 (Suppl 1): S3-12.
40. Hechler B, Nonne C, Eckly A, Magnenat S, Rinckel JY, Denis CV, Freund M, Cazenave JP, Lanza F, Gachet C. 2010. Arterial thrombosis: Relevance of a model with two levels of severity assessed by histologic, ultrastructural and functional characterization. J Thromb Haemost 8: 173-184.
41. Heemskerk JW, Siljander P, Vuist WM, Breikers G, Reutelingsperger CP, Barnes MJ, Knight CG, Lassila R, Farndale RW. 1999. Function of glycoprotein VI and integrin α2β 1 in the procoagulant response of single, collagen-adherent platelets. Thromb Haemost 81: 782-792.
42. Henrita van Zanten G, Saelman EU, Schut-Hese KM, Wu YP, Slootweg PJ, Nieuwenhuis HK, de Groot PG, Sixma JJ. 1996. Platelet adhesion to collagen type IV under flow conditions. Blood 88: 3862-3871.
43. Hermans C, Wittevrongel C, Thys C, Smethurst PA, Van Geet C, Freson K. 2009. A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder. J Thromb Haemost 7: 1356-1363.
44. Hodivala-Dilke KM, McHugh KP, Tsakiris DA, Rayburn H, Crowley D, Ullman-Cullere M, Ross FP, Coller BS, Teitelbaum S, Hynes RO. 1999. β3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest 103: 229-238.
45. Horii K, Kahn ML, Herr AB. 2006. Structural basis for platelet collagen responses by the immune-type receptor glycoprotein VI. Blood 108: 936-942.
46. Huizinga EG, Tsuji S, Romijn RA, Schiphorst ME, de Groot PG, Sixma JJ, Gros P. 2002. Structures of glycoprotein Ibα and its complex with von Willebrand factor A1 domain. Science 297: 1176-1179.
47. Hynes RO. 1990. Fibronectins. Springer-Verlag, New York.
48. Hynes RO. 2002. Integrins: Bidirectional, allosteric signaling machines. Cell 110: 673-687.
49. Ill CR, Engvall E, Ruoslahti E. 1984. Adhesion of platelets to laminin in the absence of activation. J Cell Biol 99: 2140-2145.
50. Inoue O, Suzuki-Inoue K, McCarty OJ, Moroi M, Ruggeri ZM, Kunicki TJ, Ozaki Y, Watson SP. 2006. Laminin stimulates spreading of platelets through integrin α6β 1-dependent activation of GPVI. Blood 107: 1405-1412.
51. Jarvis GE, Atkinson BT, Snell DC, Watson SP. 2002. Distinct roles of GPVI and integrin α(2)β (1) in platelet shape change and aggregation induced by different collagens. Br J Pharmacol 137: 107-117.
52. Jirouskova M, Chereshnev I, Vaananen H, Degen JL, Coller BS. 2004. Antibody blockade or mutation of the fibrinogen γ -chain C-terminus is more effective in inhibiting murine arterial thrombus formation than complete absence of fibrinogen. Blood 103: 1995-2002.
53. Jung SM, Moroi M. 2008. Platelet glycoprotein VI. Adv Exp Med Biol 640: 53-63.
54. Jung SM, Takemura Y, Imamura Y, Hayashi T, Adachi E, Moroi M. 2008. Collagen-type specificity of glycoprotein VI as a determinant of platelet adhesion. Platelets 19: 32-42.
55. Kato K, Kanaji T, Russell S, Kunicki TJ, Furihata K, Kanaji S, Marchese P, Reininger A, Ruggeri ZM, Ware J. 2003. The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood 102: 1701-1707.
56. Kehrel B, Balleisen L, Kokott R, Mesters R, Stenzinger W, Clemetson KJ, van de Loo J. 1988. Deficiency of intact thrombospondin and membrane glycoprotein Ia in platelets with defective collagen-induced aggregation and spontaneous loss of disorder. Blood 71: 1074-1078.
57. Kim J, Zhang CZ, Zhang X, Springer TA. 2010. A mechanically stabilized receptor-ligand flex-bond important in the vasculature. Nature 466: 992-995.
58. Knight CG, Morton LF, Onley DJ, Peachey AR, Ichinohe T, Okuma M, Farndale RW, Barnes MJ. 1999. Collagenplatelet interaction: Gly-Pro-Hyp is uniquely specific for platelet Gp VI and mediates platelet activation by collagen. Cardiovasc Res 41: 450-457.
59. Kuijpers MJ, Pozgajova M, Cosemans JM, Munnix IC, Eckes B, Nieswandt B, Heemskerk JW. 2007. Role of murine integrin α 2β 1 in thrombus stabilization and embolization: Contribution of thromboxane A2. Thromb Haemost 98: 1072-1080.
60. Kuijpers MJ, Gilio K, Reitsma S, Nergiz-Unal R, Prinzen L, Heeneman S, Lutgens E, van Zandvoort MA, Nieswandt B, Egbrink MG, et al. 2009. Complementary roles of platelets and coagulation in thrombus formation on plaques acutely ruptured by targeted ultrasound treatment: A novel intravital model. J Thromb Haemost 7: 152-161.
61. Kulkarni S, Dopheide SM, Yap CL, Ravanat C, Freund M, Mangin P, Heel KA, Street A, Harper IS, Lanza F, et al. 2000. A revised model of platelet aggregation. J Clin Invest 105: 783-791.
62. Kunicki TJ, Kritzik M, Annis DS, Nugent DJ. 1997. Hereditary variation in platelet integrin α2β1 density is associated with two silent polymorphisms in the α2 gene coding sequence. Blood 89: 1939-1943.
63. Lammle B, Kremer Hovinga JA, Alberio L. 2005. Thrombotic thrombocytopenic purpura. J Thromb Haemost 3: 1663-1675.
64. Leask A, Abraham DJ. 2004. TGF-β signaling and the fibrotic response. FASEB J 18:816-827.
65. Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, Yang AY, Siemieniak DR, Stark KR, Gruppo R, et al. 2001. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413: 488-494.
66. Li Z, Delaney MK, O'Brien KA, Du X. 2010. Signaling during platelet adhesion and activation. Arterioscler Thromb Vasc Biol 30: 2341-2349.
67. Loike JD, Sodeik B, Cao L, Leucona S, Weitz JI, Detmers PA, Wright SD, Silverstein SC. 1991. CD11c/CD18 on neutrophils recognizes a domain at the N terminus of the A α chain of fibrinogen. Proc Natl Acad Sci 88: 1044-1048.
68. Lou J, Zhu C. 2008. Flow induces loop-to-β-hairpin transition on the β -switch of platelet glycoprotein Ibα. Proc Natl Acad Sci 105: 13847-13852.
69. Luo SZ, Mo X, Afshar-Kharghan V, Srinivasan S, Lopez JA, Li R. 2007. Glycoprotein Ibα forms disulfide bonds with 2 glycoprotein Ibβ subunits in the resting platelet. Blood 109: 603-609.
70. Matuskova J, Chauhan AK, Cambien B, Astrof S, Dole VS, Piffath CL, Hynes RO, Wagner DD. 2006. Decreased plasma fibronectin leads to delayed thrombus growth in injured arterioles. Arterioscler Thromb Vasc Biol 26: 1391-1396.
71. Maurer LM, Tomasini-Johansson BR, Mosher DF. 2010. Emerging roles of fibronectin in thrombosis. Thromb Res 125: 287-291.
72. Medved L, Nieuwenhuizen W. 2003.Molecular mechanisms of initiation of fibrinolysis by fibrin. Thromb Haemost 89:409-419.
73. 239! Val) reported in patients with platelet-type von Willebrand disease. Blood 90: 698-705.
74. Moroi M, Jung SM, Okuma M, Shinmyozu K. 1989. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest 84: 1440-1445.
75. Moser M, Nieswandt B, Ussar S, Pozgajova M, Fassler R. 2008. Kindlin-3 is essential for integrin activation and platelet aggregation. Nat Med 14: 325-330.
76. Motto DG, Chauhan AK, Zhu G, Homeister J, Lamb CB, Desch KC, Zhang W, Tsai HM, Wagner DD, Ginsburg D. 2005. Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13- deficient mice. J Clin Invest 115: 2752-2761.
77. Nelson J, McFerran NV, Pivato G, Chambers E, Doherty C, Steele D, Timson DJ. 2008. The 67 kDa laminin receptor: Structure, function and role in disease. Biosci Rep 28: 33-48.
78. Ni H, Denis CV, Subbarao S, Degen JL, Sato TN, Hynes RO, Wagner DD. 2000. Persistence of platelet thrombus formation in arterioles of mice lacking both vonWillebrand factor and fibrinogen. J Clin Invest 106: 385-392.
79. Ni H, Yuen PS, Papalia JM, Trevithick JE, Sakai T, Fassler R, Hynes RO, Wagner DD. 2003. Plasma fibronectin promotes thrombus growth and stability in injured arterioles. Proc Natl Acad Sci 100: 2415-2419.
80. Nieswandt B, Watson SP. 2003. Platelet-collagen interaction: Is GPVI the central receptor? Blood 102: 449-461.
81. Nieswandt B, Brakebusch C, Bergmeier W, Schulte V, Bouvard D, Mokhtari-Nejad R, Lindhout T, Heemskerk JW, Zirngibl H, Fassler R. 2001. Glycoprotein VI but not α2β 1 integrin is essential for platelet interaction with collagen. Embo J 20: 2120-2130.
82. Nieswandt B, Moser M, Pleines I, Varga-Szabo D, Monkley S, Critchley D, Fassler R. 2007. Loss of talin1 in platelets abrogates integrin activation, platelet aggregation, and thrombus formation in vitro and in vivo. J Exp Med 204: 3113-3118.
83. Nieuwenhuis HK, Akkerman JW, Houdijk WP, Sixma JJ. 1985. Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 318: 470-472.
84. Nurden AT. 1999. Inherited abnormalities of platelets. Thromb Haemost 82: 468-480.
85. Nurden AT. 2006. Glanzmann thrombasthenia. Orphanet J Rare Dis 1: 10. doi: 10.1186/1750-1172-1-10.
86. Nuyttens BP, Thijs T, Deckmyn H, Broos K. 2011. Platelet adhesion to collagen. Thromb Res 127 (Suppl 2): S26-S29.
87. Ozaki Y, Suzuki-Inoue K, Inoue O. 2009. Novel interactions in platelet biology: CLEC-2/podoplanin and laminin/ GPVI. J Thromb Haemost 7 (Suppl 1): 191-194.
88. Penz S, Reininger AJ, Brandl R, Goyal P, Rabie T, Bernlochner I, Rother E, Goetz C, Engelmann B, Smethurst PA, et al. 2005. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI. FASEB J 19: 898-909.
89. Petrich BG, Marchese P, Ruggeri ZM, Spiess S, Weichert RA, Ye F, Tiedt R, Skoda RC, Monkley SJ, Critchley DR, et al. 2007. Talin is required for integrin-mediated platelet function in hemostasis and thrombosis. J Exp Med 204: 3103-3111.
90. Reheman A, Yang H, Zhu G, Jin W, He F, Spring CM, Bai X, Gross PL, Freedman J, Ni H. 2009. Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and vonWillebrand factor. Blood 113: 1809-1817.
91. Reininger AJ, Bernlochner I, Penz SM, Ravanat C, Smethurst P, Farndale RW, Gachet C, Brandl R, Siess W. 2010. A 2-step mechanism of arterial thrombus formation induced by human atherosclerotic plaques. J Am Coll Cardiol 55: 1147-1158.
92. Ricard-Blum S. 2011. The collagen family. Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a004978.
93. Ruggeri ZM. 1997. vonWillebrand factor. J Clin Invest 100: S41-S46.
94. Ruggeri ZM. 2002. Platelets in atherothrombosis. Nat Med 8: 1227-1234.
95. Russell SD, Roth GJ. 1993. Pseudo-von Willebrand disease: A mutation in the platelet glycoprotein Iba gene associated with a hyperactive surface receptor. Blood 81: 1787-1791.
96. Sadler JE. 2008. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood 112: 11-18.
97. Sadler JE. 2009. Von Willebrand factor assembly and secretion. J Thromb Haemost 7 (Suppl 1): 24-27.
98. Savage B, Saldivar E, Ruggeri ZM. 1996. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 84: 289-297.
99. Schneider SW, Nuschele S, Wixforth A, Gorzelanny C, Alexander-Katz A, Netz RR, Schneider MF. 2007. Shear-induced unfolding triggers adhesion of vonWillebrand factor fibers. Proc Natl Acad Sci 104: 7899-7903.
100. Schulz C, Penz S, Hoffmann C, Langer H, Gillitzer A, Schneider S, Brandl R, Seidl S, Massberg S, Pichler B, et al. 2008. Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo. Basic Res Cardiol 103: 356-367.
101. Schwarzbauer J, DeSimone D. 2011. Fibronectins, their fibrillogenesis, and in vivo functions. Cold Spring Harb Perspect Biol 3: doi: 10.1101/cshperspect.a005041.
102. Shattil SJ, Newman PJ. 2004. Integrins: Dynamic scaffolds for adhesion and signaling in platelets. Blood 104: 1606-1615.
103. Siller-Matula JM, Krumphuber J, Jilma B. 2010. Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases. Br J Pharmacol 159: 502-517.
104. Sixt M, Engelhardt B, Pausch F, Hallmann R, Wendler O, Sorokin LM. 2001. Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis. J Cell Biol 153: 933-946.
105. Sonnenberg A, Modderman PW, Hogervorst F. 1988. Laminin receptor on platelets is the integrin VLA-6. Nature 336: 487-489.
106. Stefanini L, Roden RC, Bergmeier W. 2009. CalDAG-GEFI is at the nexus of calcium-dependent platelet activation. Blood 114: 2506-2514.
107. Stegner D, Nieswandt B. 2011. Platelet receptor signaling in thrombus formation. J Mol Med (Berl) 89: 109-121.
108. Tandon NN, Holland EA, Kralisz U, Kleinman HK, Robey FA, Jamieson GA. 1991. Interaction of human platelets with laminin and identification of the 67 kDa laminin receptor on platelets. Biochem J 274 (Pt 2): 535-542.
109. Varga-Szabo D, Pleines I, Nieswandt B. 2008. Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol 28: 403-412.
110. Veyradier A, Lavergne JM, Ribba AS, Obert B, Loirat C, Meyer D, Girma JP. 2004. Ten candidate ADAMTS13 mutations in six French families with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome). J Thromb Haemost 2: 424-429.
111. Voss B, Rauterberg J. 1986. Localization of collagen types I, III, IV and V, fibronectin and laminin in human arteries by the indirect immunofluorescence method. Pathol Res Pract 181: 568-575.
112. Wagenseil JE, Mecham RP. 2009. Vascular extracellular matrix and arterial mechanics. Physiol Rev 89: 957-989.
113. Wagner DD. 1990. Cell biology of von Willebrand factor. Annu Rev Cell Biol 6: 217-246.
114. Ware J, Russell S, Ruggeri ZM. 2000. Generation and rescue of a murine model of platelet dysfunction: The Bernard- Soulier syndrome. Proc Natl Acad Sci 97: 2803-2808.
115. Weiss HJ, Sussman II, Hoyer LW. 1977. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. J Clin Invest 60: 390-404.
116. Wickström SA, Radovanac K, Fässler R. 2011. Genetic analyses of integrin signaling. Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a005116.
117. Wright SD, Weitz JI, Huang AJ, Levin SM, Silverstein SC, Loike JD. 1988. Complement receptor type three (CD11c/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen. Proc Natl Acad Sci 85: 7734-7738.
118. Yurchenco P. 2011. Basement membranes: Cell scaffoldings and signaling platforms. Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a004911.
119. Zhang X, Halvorsen K, Zhang CZ, Wong WP, Springer TA. 2009. Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor. Science 324: 1330-1334.
120. Zhou Z, Nguyen TC, Guchhait P, Dong JF. 2010. VonWillebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura. Semin Thromb Hemost 36: 71-81.